|
|
#1
04-21-2016, 03:29 PM
|
|||
|
|||
AbbVie gets option on early Argenx cancer drug for $40 million
(Reuters) - AbbVie has acquired an option on an early-stage immu**-oncology drug from biotech company Argenx, giving the U.S. drugmaker access to a treatment with the potential to block a biological pathway that allows cancers to grow. ??????? ??????: AbbVie gets option on early Argenx cancer drug for $40 million || ??????: ahlam1399 || ??????: اسم منتداك
|
 |
|
|
العرض العادي
